Structure-based macrocyclization yields hepatitis C virus NS5B inhibitors with improved binding affinities and pharmacokinetic properties.
Cummings, M.D., Lin, T.I., Hu, L., Tahri, A., McGowan, D., Amssoms, K., Last, S., Devogelaere, B., Rouan, M.C., Vijgen, L., Berke, J.M., Dehertogh, P., Fransen, E., Cleiren, E., van der Helm, L., Fanning, G., Van Emelen, K., Nyanguile, O., Simmen, K., Raboisson, P., Vendeville, S.(2012) Angew Chem Int Ed Engl 51: 4637-4640
- PubMed: 22473861 Search on PubMed
- DOI: https://doi.org/10.1002/anie.201200110
- Primary Citation Related Structures: 
4DRU - Janssen Infectious Diseases BVBA, Turnhoutseweg 30, 2340 Beerse, Belgium. mcummin1@its.jnj.com
Organizational Affiliation: 
















